 CAMBRIDGE, Mass.--BUSINESS WIRE--Vedanta Biosciences, a clinical-stage company that is developing a potential new category of oral therapies based on defined bacterial consortia, today announced that Bernat Olle, Ph.D., chief executive officer of Vedanta Biosciences, will participate in a panel and present at the virtual Chardan Metagenomics and Microbiome Medicines Summit on Tuesday, March 1, 2022. Chardans 2022 Metagenomics and Microbiome Medicines Summit Date: Tuesday, March 1, 2022 Panel 